Loomis Sayles & CO L P Bridge Bio Pharma, Inc. Transaction History

Loomis Sayles & CO L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $4.65 Million - $21.8 Million	-408,562 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $5.32 Million - $7.29 Million	113,537 Added 38.48%	408,562 $19.1 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $13.7 Million - $18.9 Million	295,025 New	295,025 $18 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.